Literature DB >> 33681246

Bergamo and Covid-19: How the Dark Can Turn to Light.

Norberto Perico1, Stefano Fagiuoli2, Fabiano Di Marco3, Andrea Laghi4, Roberto Cosentini5, Marco Rizzi6, Andrea Gianatti7, Alessandro Rambaldi8,9, Piero Ruggenenti10, Carlo La Vecchia11, Guido Bertolini1, Stefano Paglia12, Ferdinando Luca Lorini13, Giuseppe Remuzzi1.   

Abstract

The novel coronavirus, SARS-CoV-2, continues to spread rapidly. Here we discuss the dramatic situation created by COVID-19 in Italy, particularly in the province of Bergamo (the most severely affected in the first wave), as an example of how, in the face of an unprecedented tragedy, acting (albeit belatedly)-including imposing a very strict lockdown-can largely resolve the situation within approximately 2 months. The measures taken here ensured that Bergamo hospital, which was confronted with rapidly rising numbers of severely ill COVID-19 patients requiring hospitalization, was able to meet the initial challenges of the pandemic. We also report that local organization and, more important, the large natural immunity against SARS-CoV-2 of the Bergamo population developed during the first wave of the epidemic, can explain the limited number of new COVID-19 cases during the more recent second wave compared to the numbers in other areas of Lombardy. Furthermore, we highlight the importance of coordinating the easing of containment measures to avoid what is currently observed in other countries, especially in the United States, Latin American and India, where this approach has not been adopted, and a dramatic resurgence of COVID-19 cases and an increase in the number of hospitalisations and deaths have been reported.
Copyright © 2021 Perico, Fagiuoli, Di Marco, Laghi, Cosentini, Rizzi, Gianatti, Rambaldi, Ruggenenti, La Vecchia, Bertolini, Paglia, Lorini and Remuzzi.

Entities:  

Keywords:  Bergamo hospital challenges and reorganization; COVID-19 in Bergamo; Italian National Health Service; SARS-CoV-2 containment measures; SARS-CoV-2 infection spread; lockdown and face masks; second wave of SARS-CoV-2 infection

Year:  2021        PMID: 33681246      PMCID: PMC7933506          DOI: 10.3389/fmed.2021.609440

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  7 in total

1.  The changing pattern of bacterial and fungal respiratory isolates in patients with and without COVID-19 admitted to intensive care unit.

Authors:  Gianluca Zuglian; Diego Ripamonti; Alessandra Tebaldi; Marina Cuntrò; Ivano Riva; Claudio Farina; Marco Rizzi
Journal:  BMC Infect Dis       Date:  2022-02-23       Impact factor: 3.090

2.  Clinical predictors of late SARS-CoV-2 positivity in Italian internal medicine wards.

Authors:  Federico Carbone; Stefano Ministrini; Sara Garbarino; Giulia Vischi; Valeria Carpaneto; Matteo Sobrero; Chiara Monti; Daria De Stefano; Benedetta Saccomanno; Marcella Massone; Luca Liberale; Arianna Piccardo; Alessandro Calvia; Federica Vischi; Maddalena Bagnasco; Ottavia Magnani; Matteo Caiti; Elisabetta Cenni; Paola Ballarino; Patrizia Giuntini; Alessandra Barreca; Chiara Tognoni; Federica Pirisi; Paolo Canepa; Domenico Cerminara; Lisa Pelanconi; Michele Strozzi; Amedeo Thneibat; Mario Stabile; Edineia Felix; Selena Dasso; Cecilia Casini; Alberto Minetti; Roberta Gonella; Fabio Ferrando; Andrea Bellodi; Alberto Ballestrero; Paolo Barbera; Andrea Lorenzo Poggi; Eleonora Arboscello; Aldo Pende; Paolo Moscatelli; Michele Piana; Fabrizio Montecucco
Journal:  Eur J Clin Invest       Date:  2021-11-08       Impact factor: 5.722

3.  An in silico pipeline approach uncovers a potentially intricate network involving spike SARS-CoV-2 RNA, RNA vaccines, host RNA-binding proteins (RBPs), and host miRNAs at the cellular level.

Authors:  Massimiliano Chetta; Marina Tarsitano; Maria Oro; Maria Rivieccio; Nenad Bukvic
Journal:  J Genet Eng Biotechnol       Date:  2022-09-06

Review 4.  Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents.

Authors:  Norberto Perico; Monica Cortinovis; Fredy Suter; Giuseppe Remuzzi
Journal:  Lancet Infect Dis       Date:  2022-08-25       Impact factor: 71.421

5.  A simple, home-therapy algorithm to prevent hospitalisation for COVID-19 patients: A retrospective observational matched-cohort study.

Authors:  Fredy Suter; Elena Consolaro; Stefania Pedroni; Chiara Moroni; Elena Pastò; Maria Vittoria Paganini; Grazia Pravettoni; Umberto Cantarelli; Nadia Rubis; Norberto Perico; Annalisa Perna; Tobia Peracchi; Piero Ruggenenti; Giuseppe Remuzzi
Journal:  EClinicalMedicine       Date:  2021-06-09

6.  Covid-19: Regional policies and local infection risk: Evidence from Italy with a modelling study.

Authors:  Gabriele Guaitoli; Roberto Pancrazi
Journal:  Lancet Reg Health Eur       Date:  2021-07-15

Review 7.  [COVID-19 patients in Germany: exposure risks and associated factors for hospitalization and severe disease].

Authors:  Uwe Koppe; Hendrik Wilking; Thomas Harder; Walter Haas; Ute Rexroth; Osamah Hamouda
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-07-29       Impact factor: 1.513

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.